{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=TAC&page=9", "query": { "intervention": "TAC", "page": 9 }, "page_size": 10 }, "pagination": { "page": 9, "page_size": 10, "total_count": 389, "total_pages": 39, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=TAC&page=10&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=TAC&page=8&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-21T19:58:02.297Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02255032", "title": "Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Uveitis", "Macular Edema", "Uveitis, Posterior", "Uveitis, Anterior", "Panuveitis", "Uveitis, Intermediate" ], "interventions": [ { "name": "4 mg CLS-TA", "type": "DRUG" }, { "name": "0.8 mg CLS-TA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Clearside Biomedical, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 22, "start_date": "2014-10", "completion_date": "2016-01", "has_results": true, "last_update_posted_date": "2021-02-08", "last_synced_at": "2026-10-21T19:58:02.297Z", "location_count": 11, "location_summary": "Miami, Florida • Atlanta, Georgia • Chicago, Illinois + 8 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Waltham", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02255032" }, { "nct_id": "NCT05526898", "title": "Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Knee Osteoarthritis", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Knee Osteoarthritis" ], "interventions": [ { "name": "SyntrFuge System", "type": "DEVICE" }, { "name": "Triamcinolone Injection", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Syntr Health Technologies, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 180, "start_date": "2027-12-01", "completion_date": "2030-12", "has_results": false, "last_update_posted_date": "2026-08-20", "last_synced_at": "2026-10-21T19:58:02.297Z", "location_count": 2, "location_summary": "Irvine, California", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "Irvine", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05526898" }, { "nct_id": "NCT00367133", "title": "Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetic Macular Edema" ], "interventions": [ { "name": "Standard of Care Group", "type": "PROCEDURE" }, { "name": "1mg triamcinolone acetonide", "type": "DRUG" }, { "name": "4mg triamcinolone acetonide", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "Jaeb Center for Health Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 840, "start_date": "2004-07", "completion_date": "2008-10", "has_results": true, "last_update_posted_date": "2016-08-26", "last_synced_at": "2026-10-21T19:58:02.297Z", "location_count": 84, "location_summary": "Little Rock, Arkansas • Baldwin Park, California • Beverly Hills, California + 67 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Baldwin Park", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Loma Linda", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00367133" }, { "nct_id": "NCT02613455", "title": "Corticosteroid Injection Verses High Energy Extracorporeal Shock Wave Therapy for Lateral Epicondylitis", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Lateral Epicondylitis", "Tennis Elbow" ], "interventions": [ { "name": "extracorporeal shock wave therapy", "type": "PROCEDURE" }, { "name": "Kenalog (triamcinolone)", "type": "DRUG" }, { "name": "lidocaine 1% (lidocaine HCl 20mg)", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "Walter Reed National Military Medical Center", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2015-07", "completion_date": null, "has_results": false, "last_update_posted_date": "2015-11-24", "last_synced_at": "2026-10-21T19:58:02.297Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02613455" }, { "nct_id": "NCT02576938", "title": "A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Baricitinib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Triamcinolone (Optional)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 124, "start_date": "2016-02", "completion_date": "2017-03", "has_results": true, "last_update_posted_date": "2020-06-17", "last_synced_at": "2026-10-21T19:58:02.297Z", "location_count": 10, "location_summary": "Los Angeles, California • Tampa, Florida • Atlanta, Georgia + 6 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02576938" }, { "nct_id": "NCT00365365", "title": "Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Doxorubicin and cyclophosphamide (AC) + bevacizumab", "type": "DRUG" }, { "name": "Docetaxel (T) + bevacizumab", "type": "DRUG" }, { "name": "Docetaxel, doxorubicin, cyclophosphamide (TAC) + bevacizumab", "type": "DRUG" }, { "name": "Docetaxel, carboplatin, trastuzumab (TCH) + bevacizumab", "type": "DRUG" }, { "name": "Bevacizumab and trastuzumab maintenance therapy", "type": "DRUG" }, { "name": "Bevacizumab maintenance therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 214, "start_date": "2006-08", "completion_date": "2011-10", "has_results": true, "last_update_posted_date": "2012-09-14", "last_synced_at": "2026-10-21T19:58:02.297Z", "location_count": 1, "location_summary": "Bridgewater, New Jersey", "locations": [ { "city": "Bridgewater", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00365365" }, { "nct_id": "NCT01789320", "title": "Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Uveitis", "Intermediate Uveitis", "Posterior Uveitis", "Panuveitis", "Noninfectious Uveitis" ], "interventions": [ { "name": "triamcinolone acetonide (Triesence®)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Clearside Biomedical, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11, "start_date": "2013-02", "completion_date": "2015-03", "has_results": true, "last_update_posted_date": "2021-02-21", "last_synced_at": "2026-10-21T19:58:02.297Z", "location_count": 3, "location_summary": "Chicago, Illinois • Omaha, Nebraska • Cleveland, Ohio", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Omaha", "state": "Nebraska" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01789320" }, { "nct_id": "NCT01054703", "title": "Clinical Evaluation of the Ethmoid Sinus Spacer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Sinusitis, Chronic Rhinosinusitis" ], "interventions": [ { "name": "Ethmoid Sinus Spacer", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Integra LifeSciences Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 14, "start_date": "2007-04-01", "completion_date": "2007-11-01", "has_results": true, "last_update_posted_date": "2024-08-06", "last_synced_at": "2026-10-21T19:58:02.297Z", "location_count": 1, "location_summary": "Savannah, Georgia", "locations": [ { "city": "Savannah", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01054703" }, { "nct_id": "NCT00019227", "title": "Monoclonal Antibody Therapy in Treating Patients With Leukemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Lymphoma", "Radiation Toxicity" ], "interventions": [ { "name": "pentetic acid calcium", "type": "DRUG" }, { "name": "yttrium Y 90 daclizumab", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": "1996-10", "completion_date": "2006-07", "has_results": false, "last_update_posted_date": "2013-06-20", "last_synced_at": "2026-10-21T19:58:02.297Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00019227" }, { "nct_id": "NCT06004882", "title": "Peripheral Nerve Stimulation of Genicular Nerves Versus Conventional Therapy With Intra-articular Steroid Injection for Chronic Knee Pain: A Prospective, Randomized Pilot Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Peripheral Nerve Stimulation", "Genicular Nerves", "Chronic Knee Pain" ], "interventions": [ { "name": "PNS therapy", "type": "OTHER" }, { "name": "Triamcinolone", "type": "DRUG" }, { "name": "Bupivacaine", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 45, "start_date": "2023-08-10", "completion_date": "2027-01-31", "has_results": false, "last_update_posted_date": "2026-08-12", "last_synced_at": "2026-10-21T19:58:02.297Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06004882" } ] }